Veradigm Strengthens Leadership with Appointment of Christian Greyenbuhl as Chief Financial Officer
Veradigm Inc. (OTCMKTS: MDRX), a prominent provider of clinical, financial, and data-driven solutions designed to support independent healthcare practices, has announced the appointment of Christian Greyenbuhl as its new Chief Financial Officer (CFO). His appointment will become effective on the later of May 11, 2026, or the first business day following the company’s filing of its overdue Annual Reports on Form 10-K for the 2023 and 2024 fiscal years, unless otherwise mutually agreed upon.
This strategic leadership addition comes at a critical time for Veradigm as the company works to strengthen its financial reporting processes, restore compliance with regulatory requirements, and accelerate its long-term growth strategy. The appointment reflects the company’s commitment to rebuilding operational momentum and enhancing financial oversight.
A Seasoned Financial Leader Joins at a Pivotal Moment
Christian Greyenbuhl brings more than 25 years of experience in finance, operations, and corporate leadership across both publicly traded and privately held global organizations. Known for his strong operational mindset and ability to lead complex transformations, Greyenbuhl has consistently demonstrated success in managing financial organizations and driving business performance improvements.
Most recently, he served as Chief Financial Officer at Ministry Brands, a software-as-a-service (SaaS) technology company, where he oversaw all financial functions beginning in November 2022. During his tenure, he played a key role in strengthening financial operations and supporting business scalability.
Prior to that, Greyenbuhl held senior leadership roles at Xplor Technologies LLC, where he was Senior Vice President of Corporate Finance and Investor Relations. His career also includes over a decade at Automatic Data Processing, Inc. (ADP), where he held multiple senior positions, including leading business units as a general manager. His dual experience as both a finance executive and operational leader distinguishes him as a well-rounded executive capable of aligning financial strategy with business execution.
Earlier in his career, Greyenbuhl spent 11 years at PricewaterhouseCoopers (PwC), working with a wide range of clients across industries. This foundational experience provided him with deep expertise in accounting, auditing, and financial reporting—skills that are particularly valuable given Veradigm’s current focus on regulatory compliance and financial transparency.
Supporting Veradigm’s Strategic Transformation
Veradigm’s leadership emphasized that Greyenbuhl’s appointment aligns closely with the company’s ongoing transformation strategy, described as “Reset, Recover, Reignite.” This initiative focuses on stabilizing the company’s operations, restoring its market position, and driving sustainable, profitable growth.
Donald Trigg, Chief Executive Officer of Veradigm, highlighted the importance of this leadership addition, noting that the company has made meaningful progress in addressing its financial reporting obligations and strengthening internal processes.
He stated that with Greyenbuhl joining the executive team, Veradigm is nearing completion of the leadership structure needed to execute its strategic priorities. These include regaining momentum in serving independent physician practices, enhancing product offerings, and leveraging data-driven insights to improve healthcare outcomes.
Greyenbuhl’s Vision for the Future
Upon accepting the role, Greyenbuhl expressed enthusiasm about joining Veradigm during a transformative period. He emphasized the company’s strong market position and unique capabilities, particularly its ability to harness data and technology to deliver actionable insights across the healthcare ecosystem.
He noted that Veradigm has a significant opportunity to enhance value for healthcare providers, health plans, and biopharma organizations by improving efficiency, closing care gaps, and enabling better decision-making.
Greyanbuhl also underscored his commitment to strengthening the company’s financial foundation. He indicated that his immediate priorities will include ensuring that Veradigm becomes current with its regulatory filings, reinforcing financial controls, and supporting initiatives that drive long-term profitability.
Transition from Interim Leadership
Greyanbuhl will succeed Lee Westerfield, who has been serving as Interim Chief Financial Officer during a period of leadership transition. Westerfield played a critical role in guiding the company through a challenging phase, particularly in addressing delayed financial filings and improving liquidity.
Following the transition, Westerfield will continue to support Veradigm in a consulting capacity to ensure a smooth handover of responsibilities and maintain continuity in financial operations.
CEO Donald Trigg expressed appreciation for Westerfield’s contributions, acknowledging his dedication and leadership during a time of significant organizational change. He credited Westerfield with advancing key initiatives related to financial reporting and strengthening the company’s financial position.
Veradigm’s Role in the Healthcare Ecosystem
Veradigm has established itself as a trusted partner for independent healthcare practices, offering a range of solutions designed to improve both clinical outcomes and financial performance. The company’s technology platform connects more than 20,000 provider practices with health plans and biopharmaceutical organizations.
Through its AI-driven data capabilities, Veradigm enables stakeholders across the healthcare system to identify inefficiencies, address gaps in care, and enhance overall system affordability. Its solutions are particularly valuable in helping independent practices navigate the complexities of modern healthcare delivery while maintaining operational efficiency.
The company’s focus on innovation and data integration positions it well to capitalize on emerging trends in healthcare, including value-based care, interoperability, and digital transformation.
Addressing Financial Reporting Challenges
A key focus for Veradigm remains its efforts to become current with its financial reporting obligations. The company has experienced delays in filing its Annual Reports for recent fiscal years, which has impacted its regulatory standing and investor confidence.
The appointment of an experienced CFO like Greyenbuhl is expected to accelerate progress in resolving these challenges. His background in financial systems transformation and regulatory compliance will be instrumental in strengthening internal controls and ensuring timely and accurate reporting moving forward.
Forward-Looking Considerations
While Veradigm is optimistic about its future, the company acknowledges that it faces a number of risks and uncertainties. These include potential delays in completing financial filings, challenges in maintaining compliance with regulatory requirements, and the possibility of identifying additional issues during ongoing audits and remediation efforts.
Additionally, the company’s stock currently does not trade on a national securities exchange, which presents further challenges related to market visibility and investor engagement.
Despite these risks, Veradigm remains focused on executing its strategic plan, strengthening its leadership team, and delivering value to its customers and stakeholders.
The appointment of Christian Greyenbuhl as Chief Financial Officer marks an important milestone for Veradigm as it continues its transformation journey. With his extensive experience, operational expertise, and proven leadership, Greyenbuhl is well-positioned to help the company navigate its current challenges and capitalize on future opportunities.
As Veradigm works to restore compliance, enhance its financial foundation, and drive innovation in healthcare technology, the addition of a seasoned executive like Greyenbuhl reinforces its commitment to long-term success.
About Veradigm®
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.
© 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.
